CVS Group (LON:CVSG) Hits New 52-Week High – Time to Buy?

CVS Group plc (LON:CVSG – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Monday. The company traded as high as GBX 1,432 and last traded at GBX 1,423, with a volume of 21,952 shares changing hands. The stock had previously closed at GBX 1,412.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on CVSG shares. Berenberg Bank restated a “buy” rating and issued a GBX 2,000 price target on shares of CVS Group in a report on Thursday, September 24th. Shore Capital Group reiterated a “hold” rating and set a GBX 1,400 price objective on shares of CVS Group in a report on Thursday, September 24th. Jefferies Financial Group reiterated a “hold” rating and issued a GBX 1,400 price objective on shares of CVS Group in a research report on Friday, September 25th. Finally, Deutsche Bank reiterated a “buy” rating and issued a GBX 1,700 price objective on shares of CVS Group in a research report on Monday, July 27th. Four analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, CVS Group has an average rating of “Moderate Buy” and a consensus target price of GBX 1,666.67.

View Our Latest Analysis on CVSG

CVS Group Price Performance

The company’s 50-day moving average price is GBX 1,285.08 and its 200-day moving average price is GBX 1,255.45. The company has a debt-to-equity ratio of 110.41, a current ratio of 1.18 and a quick ratio of 0.90. The company has a market cap of £949.58 million, a P/E ratio of 58.59, a P/E/G ratio of 1.77 and a beta of 1.04.

CVS Group (LON:CVSG – Get Free Report) last issued its quarterly earnings data on Thursday, September 24th. The company reported GBX 85.60 EPS for the quarter. CVS Group had a net margin of 2.43% and a return on equity of 5.91%. As a group, sell-side analysts predict that CVS Group plc will post 93.94 earnings per share for the current fiscal year.

About CVS Group

(Get Free Report)

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy. The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

Further Reading

Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.